Stefan Linn
2019
In 2019, Stefan Linn earned a total compensation of $1.4M as Chief Operating Officer at Oxford Immunotec Global, a 66% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $289,380 |
|---|---|
| Option Awards | $343,000 |
| Salary | $416,000 |
| Stock Awards | $343,000 |
| Other | $5,015 |
| Total | $1,396,395 |
Linn received $416K in salary, accounting for 30% of the total pay in 2019.
Linn also received $289.4K in non-equity incentive plan, $343K in option awards, $343K in stock awards and $5K in other compensation.
Rankings
In 2019, Stefan Linn's compensation ranked 7,687th out of 13,971 executives tracked by ExecPay. In other words, Linn earned more than 45.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,687 out of 13,971 | 45th |
Division Manufacturing | 3,000 out of 5,701 | 47th |
Major group Chemicals And Allied Products | 1,128 out of 2,200 | 49th |
Industry group Drugs | 962 out of 1,886 | 49th |
Industry In Vitro and In Vivo Diagnostic Substances | 23 out of 77 | 70th |
Source: SEC filing on April 29, 2020.
Linn's colleagues
We found two more compensation records of executives who worked with Stefan Linn at Oxford Immunotec Global in 2019.